Form4insider filings, from the source

SEC Form 4 · accession 0000902664-15-000568

Nexvet Biopharma plc · NVET

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Phillip Gross
10% Owner
Period of report
Feb 10, 2015
Accepted (ET)
Feb 10, 2015 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary Shares, $0.0125 nominal value ("Ordinary Shares")F1,F2Feb 10, 2014P275,000$10.00A275,000ISee footnotes
Ordinary SharesF3,F1,F2Feb 10, 2014C600,000—A875,000ISee footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preference SharesF1,F2,F3—Feb 10, 2014C600,000D——Ordinary Shares600,0000I

Explanation of responses